Company will Provide Mission-Critical Blast Exposure Monitoring System to Preserve and Maintain Readiness for Warfighters

Cadre Holdings, Inc. (NYSE: CDRE) (“Cadre” or “the Company”), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that its subsidiary Med-Eng, LLC has been awarded a 5-year Indefinite Delivery / Indefinite Quantity (ID/IQ) contract with a maximum value of $50 million by the United States Department of War (DoW) to deliver and support the Blast Exposure Monitoring (BEMO) Program. The BEMO systems, including sensor hardware and related software, measure and record blast overpressure exposures experienced in training operations as part of a DoW Brain Health program.

Cadre President Brad Williams commented, “Underscoring our leading-edge EOD capability, we are honored to be selected as the provider of a sensor technology solution that will significantly enhance the ability of the U.S. military to monitor, track, and evaluate blast overpressure exposure events warfighters receive in training. Consistent with our continuous commitment to innovation and mission of “Together, We Save Lives,” this work with the DoW also exemplifies our ability to apply electronics and software engineering capabilities to capture and transform raw data into user-friendly and highly practical solutions.

Mr. Williams continued, “We are incredibly proud to be awarded this contract, which is a testament to Med-Eng’s ability to develop best-in-class systems to aid in the mitigation of threats, support operational requirements, and keep users safe in the line of duty. I want to thank our talented team members, whose dedication, diligence, and relentless focus on excellence made this achievement possible. We look forward to delivering on this program in 2026 and exploring the possibility of how this new capability can be leveraged to support other frontline personnel.”

First delivery under the contract will begin in 2026 and follows a competitive 5-year funded development program to improve methods for identifying blast overpressure exposures impacting the warfighter while using heavy weapon systems and conducting explosive breaching in dynamic combat and training environments. Once deployed, real-time updates will be available for team leaders, commanders, and medical personnel—enabling rapid triage decisions and dynamic adjustments to tactics, techniques, and procedures (TTPs).

Med-Eng has been a pioneer in the development and fielding of body-worn blast sensors since 2006. This latest generation is a significant step forward in the convergence of hardware, mobile device apps, and intuitive dashboards to bridge the gap between blast overpressure events and longitudinal brain health monitoring. This will help team leaders, medical staff, and senior leadership to utilize powerful decision-making tools based on tracking both single event and cumulative blast overpressure exposure.

About Cadre

Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251119779120/en/